Minimal clinical impact of embolization to new territory on outcomes in medium vessel occlusion strokes treated with mechanical thrombectomy: a retrospective multicenter study.

医学 栓塞 闭塞 多中心研究 回顾性队列研究 冲程(发动机) 外科 放射科 随机对照试验 机械工程 工程类
作者
Hamza Salim,Vivek Yedavalli,Dhairya A. Lakhani,Fathi Milhem,Basel Musmar,Nimer Adeeb,Tobias D. Faizy,Motaz Daraghma,Kareem El Naamani,Nils Henninger,Sri Hari Sundararajan,Anna Luisa Kühn,Jane Khalife,Sherief Ghozy,Luca Scarcia,Inayat Grewal,Leonard L.L. Yeo,Benjamin Yong‐Qiang Tan,Robert W. Regenhardt,Jeremy J. Heit
出处
期刊:PubMed [National Institutes of Health]
标识
DOI:10.1136/jnis-2024-022570
摘要

Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study examines the impact of periprocedural embolization to a new vascular territory (ENT) on clinical outcomes in patients with MeVO stroke treated with MT. A multicenter, retrospective analysis was conducted using the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry, including 2122 patients with MeVO stroke w-ho underwent MT between September 2017 and July 2023. ENT was defined as filling defects in previously unaffected territories, excluding embolization near the original occlusion, observed on final angiographic runs after retrieval of the primary thrombus. The associations between ENT, procedural variables, and 90-day clinical outcomes were evaluated, including functional independence (modified Rankin Scale (mRS) scores of 0-2), excellent outcomes (mRS 0-1), mortality, and hemorrhagic complications. ENT occurred in 2.9% (63/2122) of patients. Longer onset-to-arterial puncture time (adjusted OR 1.03; 95% CI 1.01 to 1.05; P=0.002) and a greater number of passes (adjusted OR 1.15; 95% CI 1.01 to 1.32; P=0.032) were associated with increased ENT risk, while excellent recanalization (thrombolysis in cerebral infarction (TICI) scale score 2c-3) was associated with reduced ENT risk (adjusted OR 0.41; 95% CI 0.23 to 0.72; P=0.002). ENT was not associated with poorer functional independence, mortality, or hemorrhagic complications. ENT during MT for MeVO stroke occurs infrequently and does not significantly affect the clinical outcomes. These findings suggest ENT risk should not deter clinicians from performing MT in patients with MeVO. Further prospective studies are needed to validate these results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
落酒完成签到,获得积分20
刚刚
刚刚
六不六完成签到,获得积分10
刚刚
zhongzihao发布了新的文献求助10
2秒前
陈叉叉发布了新的文献求助10
2秒前
桐桐的应助被七听采纳,获得150
3秒前
Chow发布了新的文献求助10
3秒前
4秒前
yan完成签到,获得积分10
5秒前
神勇的又槐完成签到,获得积分10
5秒前
阔达的背包完成签到 ,获得积分10
7秒前
不说再见发布了新的文献求助10
8秒前
9秒前
9秒前
范晓圳完成签到 ,获得积分10
10秒前
11秒前
落寞涑完成签到 ,获得积分10
13秒前
13秒前
苏格拉丁发布了新的文献求助10
14秒前
14秒前
丹丹的应助被魔幻灯泡采纳,获得10
15秒前
Hello的应助被空白采纳,获得10
15秒前
范晓圳关注了科研通微信公众号
15秒前
崔祎荣发布了新的文献求助10
16秒前
16秒前
陈利发布了新的文献求助10
17秒前
17秒前
平息发布了新的文献求助100
19秒前
不羁完成签到 ,获得积分10
20秒前
真人完成签到 ,获得积分10
20秒前
冰阔罗完成签到,获得积分10
24秒前
酷波er的应助被dua采纳,获得10
24秒前
aajhajkahna的应助被ding采纳,获得10
26秒前
Athaliah完成签到,获得积分10
26秒前
Verne完成签到,获得积分10
27秒前
Yuzu完成签到,获得积分10
28秒前
完美世界的应助被五四三二一采纳,获得10
29秒前
英姑的应助被不说再见采纳,获得10
30秒前
碗四完成签到 ,获得积分10
31秒前
秋风的应助被超级尔白采纳,获得200
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 1000
Электротехническая система магнитожидкостной герметизации валов регулируемых электродвигателей 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre 666
The Basics of Practical Optimization, Second Edition 600
Practical Nonconvex Nonsmooth Optimization 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 7980706
求助须知:如何正确求助?哪些是违规求助? 9442285
关于积分的说明 21080828
捐赠科研通 7555737
什么是DOI,文献DOI怎么找? 3375725
关于科研通互助平台的介绍 2510347
邀请新用户注册赠送积分活动 2408977